Suzhou Stainwei Biotech Inc. (http://www.stainwei.cn) (http://www.stainwei-inc.com) is a China–based biotech start-up corporation dedicated to developing and commercializing novel antibody-based diagnostic and therapeutic products for cancers and immune-related diseases.
Using proprietary recombinant antibody and fusion protein technologies developed by the founders, Stainwei has made a rapid progress in